Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion

Susan M. Shea(University of Iowa), Shahid M. Nimjee(The Ohio State University Wexner Medical Center), Emily Mihalko(University of North Carolina at Chapel Hill), Bruce A. Sullenger(Duke University), Christina Daniel(Washington University in St. Louis), Kimberly A. Thomas(Washington University in St. Louis), Rassam M. G. Rassam(University of Pittsburgh), Philip C. Spinella
Pharmaceuticals
November 22, 2022
Cited by 13


Related Papers